Association Analyses of More Than 140,000 Men Identify 63 New Prostate Cancer Susceptibility Loci

Genome-wide association studies (GWAS) and fine-mapping efforts to date have identified more than 100 prostate cancer (PrCa)-susceptibility loci. We meta-analyzed genotype data from a custom high-density array of 46,939 PrCa cases and 27,910 controls of European ancestry with previously genotyped data of 32,255 PrCa cases and 33,202 controls of European ancestry. Our analysis identified 62 novel loci associated (P < 5.0 × 10) with PrCa and one locus significantly associated with early-onset PrCa (≤55 years). Our findings include missense variants rs1800057 (odds ratio (OR) = 1.16; P = 8.2 × 10; G>C, p.Pro1054Arg) in ATM and rs2066827 (OR = 1.06; P = 2.3 × 10; T>G, p.Val109Gly) in CDKN1B. The combination of all loci captured 28.4% of the PrCa familial relative risk, and a polygenic risk score conferred an elevated PrCa risk for men in the ninetieth to ninety-ninth percentiles (relative risk = 2.69; 95% confidence interval (CI): 2.55-2.82) and first percentile (relative risk = 5.71; 95% CI: 5.04-6.48) risk stratum compared with the population average. These findings improve risk prediction, enhance fine-mapping, and provide insight into the underlying biology of PrCa.

Citing Articles

The Effect of Nonalcoholic Fatty Liver Disease on Extrahepatic Cancers: Evidence From Population-Based Cohort and Mendelian Randomization.

Wang W, Sun P, Ren X, Lv T, Li M Health Sci Rep. 2025; 8(3):e70551.

PMID: 40066248 PMC: 11892145. DOI: 10.1002/hsr2.70551.

A Bidirectional Mendelian Randomization Study on the Causal Relationship Between Epstein-Barr Virus Antibodies and Prostate Cancer Risk.

Ding X, Ren S, Wen H, Zhang Z, Ye J, Pan W Cancer Control. 2025; 32:10732748251320842.

PMID: 40026212 PMC: 11873887. DOI: 10.1177/10732748251320842.

Proteome-wide Mendelian randomization identifies causal plasma proteins in prostate cancer development.

Wu J, Yang Z, Ding J, Hao S, Chen H, Jin K Hum Genomics. 2025; 19(1):17.

PMID: 39994764 PMC: 11853923. DOI: 10.1186/s40246-025-00724-x.

Insomnia in relation to 10 urological and reproductive conditions: a two-sample Mendelian randomization study.

Wu Y, Wang Y, Wang W, Xia J, Gu Y, Qian Q Transl Androl Urol. 2025; 14(1):8-14.

PMID: 39974799 PMC: 11833540. DOI: 10.21037/tau-24-444.

Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases.

Mitchell J, Camacho N, Shea P, Stopsack K, Joseph V, Burren O Nat Commun. 2025; 16(1):1779.

PMID: 39971927 PMC: 11839991. DOI: 10.1038/s41467-025-56944-1.

References

Ashburner M, Ball C, Blake J, Botstein D, Butler H, Cherry J . Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000; 25(1):25-9. PMC: 3037419. DOI: 10.1038/75556. View

Matikaine M, Pukkala E, Schleutker J, Tammela T, Koivisto P, Sankila R . Relatives of prostate cancer patients have an increased risk of prostate and stomach cancers: a population-based, cancer registry study in Finland. Cancer Causes Control. 2001; 12(3):223-30. DOI: 10.1023/a:1011283123610. View

Stanford J, Ostrander E . Familial prostate cancer. Epidemiol Rev. 2001; 23(1):19-23. DOI: 10.1093/oxfordjournals.epirev.a000789. View

Bunker C, Patrick A, Konety B, Dhir R, Brufsky A, Vivas C . High prevalence of screening-detected prostate cancer among Afro-Caribbeans: the Tobago Prostate Cancer Survey. Cancer Epidemiol Biomarkers Prev. 2002; 11(8):726-9. View

Thomas P, Campbell M, Kejariwal A, Mi H, Karlak B, Daverman R . PANTHER: a library of protein families and subfamilies indexed by function. Genome Res. 2003; 13(9):2129-41. PMC: 403709. DOI: 10.1101/gr.772403. View

Wissmann C, Wild P, Kaiser S, Roepcke S, Stoehr R, Woenckhaus M . WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer. J Pathol. 2003; 201(2):204-12. DOI: 10.1002/path.1449. View

Shannon P, Markiel A, Ozier O, Baliga N, Wang J, Ramage D . Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003; 13(11):2498-504. PMC: 403769. DOI: 10.1101/gr.1239303. View

Joshi-Tope G, Gillespie M, Vastrik I, DEustachio P, Schmidt E, de Bono B . Reactome: a knowledgebase of biological pathways. Nucleic Acids Res. 2004; 33(Database issue):D428-32. PMC: 540026. DOI: 10.1093/nar/gki072. View

Romero P, Wagg J, Green M, Kaiser D, Krummenacker M, Karp P . Computational prediction of human metabolic pathways from the complete human genome. Genome Biol. 2005; 6(1):R2. PMC: 549063. DOI: 10.1186/gb-2004-6-1-r2. View

10.

Subramanian A, Tamayo P, Mootha V, Mukherjee S, Ebert B, Gillette M . Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005; 102(43):15545-50. PMC: 1239896. DOI: 10.1073/pnas.0506580102. View

11.

Amundadottir L, Sulem P, Gudmundsson J, Helgason A, Baker A, Agnarsson B . A common variant associated with prostate cancer in European and African populations. Nat Genet. 2006; 38(6):652-8. DOI: 10.1038/ng1808. View

12.

Yeager M, Orr N, Hayes R, Jacobs K, Kraft P, Wacholder S . Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet. 2007; 39(5):645-9. DOI: 10.1038/ng2022. View

13.

Gudmundsson J, Sulem P, Manolescu A, Amundadottir L, Gudbjartsson D, Helgason A . Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet. 2007; 39(5):631-7. DOI: 10.1038/ng1999. View

14.

Meyer A, Wilhelm B, Dork T, Bremer M, Baumann R, Karstens J . ATM missense variant P1054R predisposes to prostate cancer. Radiother Oncol. 2007; 83(3):283-8. DOI: 10.1016/j.radonc.2007.04.029. View

15.

Gudmundsson J, Sulem P, Steinthorsdottir V, Bergthorsson J, Thorleifsson G, Manolescu A . Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet. 2007; 39(8):977-83. DOI: 10.1038/ng2062. View

16.

Wang K, Li M, Bucan M . Pathway-based approaches for analysis of genomewide association studies. Am J Hum Genet. 2007; 81(6):1278-83. PMC: 2276352. DOI: 10.1086/522374. View

17.

Duggan D, Zheng S, Knowlton M, Benitez D, Dimitrov L, Wiklund F . Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. J Natl Cancer Inst. 2007; 99(24):1836-44. DOI: 10.1093/jnci/djm250. View

18.

Thomas G, Jacobs K, Yeager M, Kraft P, Wacholder S, Orr N . Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet. 2008; 40(3):310-5. DOI: 10.1038/ng.91. View

19.

Eeles R, Kote-Jarai Z, Giles G, Olama A, Guy M, Jugurnauth S . Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet. 2008; 40(3):316-21. DOI: 10.1038/ng.90. View

20.

Gudmundsson J, Sulem P, Rafnar T, Bergthorsson J, Manolescu A, Gudbjartsson D . Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet. 2008; 40(3):281-3. PMC: 3598012. DOI: 10.1038/ng.89. View